Frédéric Villain

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Placebo Controlled

Top Venues

Developmental medicine and child neurology

BMJ paediatrics open

This page only lists publications with an associated author ORCID identifier.

Publications

Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz, Stéphane Rondeau, Guy Letellier, Stėphane Auvin
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial. Developmental medicine and child neurology 66 (7) (2024)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz, Stéphane Rondeau, Guy Letellier, Stėphane Auvin
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial. Developmental medicine and child neurology 66 (7) (2024)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz, Stéphane Rondeau, Guy Letellier, Stėphane Auvin
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial. Developmental medicine and child neurology (2024)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz, Stéphane Rondeau, Guy Letellier, Stėphane Auvin
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial. Developmental medicine and child neurology (2024)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz, Stéphane Rondeau, Guy Letellier, Stėphane Auvin
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial. Developmental medicine and child neurology (2024)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Frédéric Villain, Déborah Schwartz, Stéphane Rondeau, Guy Letellier, Stėphane Auvin
Glycopyrronium 320 μg/mL in children and adolescents with severe sialorrhoea and neurodisabilities: A randomized, double-blind, placebo-controlled trial. Developmental medicine and child neurology 66 (7) (2024)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Nick Probert, Frédéric Villain, Denis Pouchain, Nathalie Texier, Stėphane Auvin
Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial. BMJ paediatrics open 7 (1) (2023)
Pierre Fayoux, Mickael Dinomais, Helen Shaw, Nick Probert, Frédéric Villain, Denis Pouchain, Nathalie Texier, Stėphane Auvin
Randomised, double-blind, placebo-controlled trial of glycopyrronium in children and adolescents with severe sialorrhoea and neurodisabilities: protocol of the SALIVA trial. BMJ paediatrics open 7 (1) (2023)